Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Biological AFM

By Drug Discovery Trends Editor | September 26, 2012

Bruker has released Nanomechanics package, which significantly expands Bio-AFM applications in mechanobiology research. The package includes new analysis models in PeakForce QNM, the PeakForce Capture function, and the newly enhanced Quantitative Force-Volume Mapping mode. The new functionality in PeakForce QNM provides expanded support for a lower modulus range covering live cells and tissues, making it the best mechanical property measurement tool for soft biological samples. The PeakForce Capture function gives researchers full access to the PeakForce QNM data to explore alternate analysis models and validate their results against other techniques. Analysis capabilities in Quantitative Force-Volume Mapping mode enable direct comparisons with this widely used legacy technique. Together, these features provide the fastest, highest resolution, and most quantitative characterization of nanomechanical properties over a wide range of biological samples.

Bruker’s PeakForce QNM mode has been adopted by life science laboratories for characterizing the mechanical properties of biological materials at the nanoscale. Now expanded capabilities make it more powerful for characterizing even softer biological samples.

Bruker


Filed Under: Drug Discovery

 

Related Articles Read More >

New gonorrhea antibiotic could treat resistant infections
In door grow hemp. Cannabis at the beginning of flowering. Legal Marijuana cultivation in the home. Green background of leaves. Young cannabis plant. Medicinal indica with CBD.
Why Schedule III cannabis could be a win for Big Pharma
Red blood cells macro over red eritrosit background. Concept of blood cells count, medicine and healthcare. 3d rendering mock up
Platelet-inspired nanoparticle delivers drugs directly where they are needed
Lilly’s triple agonist delivers up to 71.2 lbs of weight loss in Phase 3 trial
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE